Pratishtha S. Chatterjee

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

The Relationship between Ergothioneine, Allantoin and Neocortical Amyloid Load.

The Relationship between Ergothioneine, Allantoin and Neocortical Amyloid Load.

Journal: Aging and disease

Published: January 21, 2026

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.

Plasma soluble TREM2 is associated with plasma pTau-181 and pTau-231 in cognitively normal older adults at risk of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: December 09, 2025

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

Circulating Sphingomyelins Correlate With Plasma T-Tau in Cognitively Unimpaired Older Adults at Risk of Developing Alzheimer's Disease.

Journal: Journal of neurochemistry

Published: November 09, 2025

Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.

Real world diagnostic performance of plasma p-tau217 for early-onset Alzheimer's disease in a cognitive disorders tertiary care setting.

Journal: Journal of Alzheimer's disease : JAD

Published: September 11, 2025

Neurofilament light chain and voice acoustics in dementia diagnosis (NAVAIDD): Protocol for a cohort study assessing the real-world diagnostic utility of blood and digital biomarkers in clinical settings.

Neurofilament light chain and voice acoustics in dementia diagnosis (NAVAIDD): Protocol for a cohort study assessing the real-world diagnostic utility of blood and digital biomarkers in clinical settings.

Journal: Journal of Alzheimer's disease reports

Published: July 01, 2025

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.

Journal: Journal of neurology

Published: September 21, 2024

Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.

Circulating medium- and long-chain acylcarnitines are associated with plasma P-tau181 in cognitively normal older adults.

Journal: Journal of neurochemistry

Published: July 26, 2024

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease.

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease.

Journal: Frontiers in neuroscience

Published: September 20, 2023

Predicting neurodegeneration from sleep related biofluid changes.

Predicting neurodegeneration from sleep related biofluid changes.

Journal: Neurobiology of disease

Published: August 07, 2023

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.

Journal: npj aging

Published: February 22, 2023

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: February 13, 2023

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis.

Journal: Nutrition reviews

Published: January 12, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026